SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Perspective Therapeutics Reports Third-Quarter 2026 Results and Business Update

Perspective Therapeutics reported its third-quarter 2026 results and provided a business update.

CATX
SquawkNews Desk

SEATTLE, Nov. 09, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective,” the “Company,” “we,” “us,” and “our”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced systemic treatments for cancers, today provided a business update and announced result…

Related stories

Viant Technology Reports Q3 Revenue of $110.4 Million, Updates Outlook Viant reported Q3 2026 revenue of $110.4 million and adjusted EPS of $0.13, below FactSet consensus of $0.19. It projects Q4 revenue of $130.5 million to $133.5 million and expects M impact | EQUITY | Nov 09, 2026, 10:41 PM UTC AbCellera reports quarterly results for period ended September 30 M impact | EQUITY | Nov 09, 2026, 10:40 PM UTC James River Group Holdings Reports Quarterly Results James River Group Holdings reported results for the quarter ended September 30. M impact | EQUITY | Nov 09, 2026, 10:40 PM UTC Ethan Allen Interiors Reports Quarterly Results Ethan Allen Interiors reported results for the quarter ended September 30; the supplied body contains no figures. M impact | EQUITY | Nov 09, 2026, 10:40 PM UTC OraSure Technologies reports quarterly results through September 30 OraSure Technologies reported results for the quarter ended September 30. The supplied text contains no financial figures. M impact | EQUITY | Nov 09, 2026, 10:39 PM UTC Hallador Energy reports quarterly results for period ended September 30 M impact | EQUITY | Nov 09, 2026, 10:38 PM UTC